Changes in density following the use of GLP-1 agonists may obfuscate previously identified and may create a clinical dilemma in the setting of actionable BI-RADS findings
Most common gastrointestinal side effects improve with time and dose stabilization rather than necessitating discontinuation
Electrolytes sodium, potassium, calcium, chloride, and magnesium work with nutrients to restore fluid balance and support cell function
Clinical data shows that dose escalation produces additional weight loss because it increases GLP-1 receptor activation
Overall, high dose VitC administered as a single agent has not only been shown to be safe and well-tolerated in cancer patients, but also to ameliorate pain and to improve quality of life in the palliative care setting
In the main this audit is trying to address the move from administration of monthly cyanocobalamin to three monthly hydroxocobalamin